NB

Navneet Bagga

Director Additional Director DIN 06786086
DIN 06786086 First appointment Feb 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Navneet Bagga

Data last updated:

Navneet Bagga was an Additional Director at Rapross Pharmaceuticals Private Limited (2023–2024) and Designated Partner at Riyons True Solutions Llp (from 2014). The companies operate in Pharma.

DIN 06786086
Primary Designation Additional Director
Industry Pharma
First Appointment 14 Feb 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director01 Aug 20231995₹29.39 Cr (FY 2023)Active
Designated Partner14 Feb 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Riyons True Solutions Llp
Rapross Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Navneet Bagga

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Navneet Bagga

Navneet Bagga was first appointed on 14 Feb 2014 as Designated Partner at Riyons True Solutions Llp. The most recent appointment on record is 01 Aug 2023 at Rapross Pharmaceuticals Private Limited.

Navneet Bagga held 2 earlier board appointments: Rapross Pharmaceuticals Private Limited (Additional Director, 01 Aug 2023 to 01 Feb 2024); Riyons True Solutions Llp (Designated Partner, from 14 Feb 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available